Analystreport

Fortress Biotech (NASDAQ: FBIO) had its price target lowered by analysts at Roth Capital from $5.00 to $4.75. They now have a "buy" rating on the stock.

Fortress Biotech, Inc.  (FBIO) 
Last fortress biotech, inc. earnings: 11/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: fortressbiotech.com